China National Medicines Corp Ltd Financial Flexibility Index
China National Medicines Corp Ltd financial flexibility index. China National Medicines Corp Ltd (600511) has a Financial Flexibility Index of -0.03x as of September 2025. Free cash flow of CN¥-520.16 Million (operating CF CN¥-540.00 Million minus capex CN¥19.84 Million) represents 0% of total liabilities (CN¥15.19 Billion). See China National Medicines Corp Ltd (600511) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of China National Medicines Corp Ltd (2001–2024)
Financial flexibility index of China National Medicines Corp Ltd from 2001 to 2024. Historical Financial Flexibility Index trend for China National Medicines Corp Ltd across 24 annual periods. Check how high is China National Medicines Corp Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
China National Medicines Corp Ltd Financial Flexibility Index by Year (2001–2024)
China National Medicines Corp Ltd financial flexibility index by year from 2001 to 2024. Year-by-year free cash flow to debt coverage for China National Medicines Corp Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of China National Medicines Corp Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.11x | CN¥1.79 Billion | CN¥1.66 Billion | CN¥15.95 Billion | ▼ -41.7% |
| 2023 | 0.19x | CN¥2.87 Billion | CN¥2.73 Billion | CN¥14.92 Billion | ▲ +4.8% |
| 2022 | 0.18x | CN¥2.52 Billion | CN¥2.40 Billion | CN¥13.75 Billion | ▲ +17.4% |
| 2021 | 0.16x | CN¥2.05 Billion | CN¥1.96 Billion | CN¥13.12 Billion | ▲ +34.8% |
| 2020 | 0.12x | CN¥1.37 Billion | CN¥1.30 Billion | CN¥11.81 Billion | ▼ -25.0% |
| 2019 | 0.15x | CN¥1.86 Billion | CN¥1.78 Billion | CN¥12.03 Billion | ▲ +51.4% |
| 2018 | 0.10x | CN¥1.11 Billion | CN¥981.65 Million | CN¥10.90 Billion | ▼ -4.6% |
| 2017 | 0.11x | CN¥1.15 Billion | CN¥1.07 Billion | CN¥10.71 Billion | ▼ -42.5% |
| 2016 | 0.19x | CN¥631.13 Million | CN¥591.25 Million | CN¥3.38 Billion | ▲ +11.5% |
| 2015 | 0.17x | CN¥508.75 Million | CN¥440.29 Million | CN¥3.04 Billion | ▲ +34.7% |
| 2014 | 0.12x | CN¥367.17 Million | CN¥218.94 Million | CN¥2.96 Billion | ▲ +16.5% |
| 2013 | 0.11x | CN¥307.22 Million | CN¥185.56 Million | CN¥2.88 Billion | ▼ -19.4% |
| 2012 | 0.13x | CN¥355.52 Million | CN¥185.87 Million | CN¥2.69 Billion | ▲ +185.6% |
| 2011 | -0.15x | CN¥-311.60 Million | CN¥-370.56 Million | CN¥2.02 Billion | ▼ -192.4% |
| 2010 | 0.17x | CN¥342.30 Million | CN¥318.21 Million | CN¥2.05 Billion | ▲ +1.9% |
| 2009 | 0.16x | CN¥277.51 Million | CN¥255.18 Million | CN¥1.69 Billion | ▼ -20.7% |
| 2008 | 0.21x | CN¥233.30 Million | CN¥217.10 Million | CN¥1.13 Billion | ▲ +188.6% |
| 2007 | 0.07x | CN¥88.09 Million | CN¥79.48 Million | CN¥1.23 Billion | ▼ -62.0% |
| 2006 | 0.19x | CN¥145.31 Million | CN¥121.50 Million | CN¥771.05 Million | ▲ +7.2% |
| 2005 | 0.18x | CN¥133.44 Million | CN¥92.20 Million | CN¥759.27 Million | ▼ -9.1% |
| 2004 | 0.19x | CN¥136.26 Million | CN¥49.18 Million | CN¥704.48 Million | ▲ +31.1% |
| 2003 | 0.15x | CN¥91.44 Million | CN¥526.15K | CN¥619.80 Million | ▲ +105.2% |
| 2002 | 0.07x | CN¥29.38 Million | CN¥15.19 Million | CN¥408.75 Million | ▲ +381.7% |
| 2001 | -0.03x | CN¥-7.68 Million | CN¥-11.80 Million | CN¥300.99 Million | — |